Cargando…
Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis
OBJECTIVES: In China, Danhong injection (DHI) is recommended by expert consensus and is widely used in the perioperative management of patients with acute coronary syndrome (ACS). This study investigates the effect of perioperative DHI administration and the timing of DHI administration on patients...
Autores principales: | Li, Yuxuan, Li, Dong, Wang, Wujiao, Li, Xingxing, Li, Peng, Zhang, Yuanyuan, Lin, Qian, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719950/ https://www.ncbi.nlm.nih.gov/pubmed/36479564 http://dx.doi.org/10.3389/fcvm.2022.1029387 |
Ejemplares similares
-
Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy
por: Gao, Mingxin, et al.
Publicado: (2023) -
Hypothyroidism predicts worsened prognosis in patients undergoing percutaneous coronary intervention
por: Cohen, Ben, et al.
Publicado: (2022) -
Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021) -
Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021) -
The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Zou, Jun-Bo, et al.
Publicado: (2018)